; and (2) provide technical and other nonfinancial assistance to e-liquid and personal electronic vaporizer manufacturers to assist them in complying with the requirements of this Act. . 5. Joint comparative health risk assessment Chapter X of the Federal Food, Drug, and Cosmetic Act, as added by section 4, is further amended by adding at the end the following: 1008. Tobacco products and nicotine delivery alternatives: comparative health risk assessment (a) Assessment The Secretary shall undertake a tobacco products and other nicotine delivery alternatives comparative health risk assessment and rank each category of products on a scale according to the reasonable expectation for morbidity and mortality risk when compared to smoking cigarettes based on laboratory studies and existing scientific data. For purposes of such assessment, tobacco and nicotine delivery alternative product categories shall include at a minimum— (1) cigarettes; (2) loose tobacco for roll-your-own tobacco products; (3) little cigars; (4) cigars; (5) pipe tobacco; (6) moist snuff; (7) dry snuff; (8) chewing tobacco; (9) snus; (10) vaporized tobacco, meaning heat not burn technology intended for inhalation; (11) vapor produced by a personalized electronic vaporizer containing e-liquid with nicotine; (12) shisha and other tobacco products that are heated and inhaled via a hookah, water pipe, or other type of pipe (treated collectively as a single category); (13) dissolvable, chewable, drinkable, and other tobacco and nicotine products intended for oral ingestion (treated collectively as a single category); (14) tobacco and nicotine skin creams, patches, and other tobacco and nicotine products intended for transdermal consumption (treated collectively as a single category); (15) tobacco and nicotine sprays, droplets, and mists intended for nasal consumption (treated as a single category)